These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23575729)

  • 21. Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems.
    Bossart KN; McEachern JA; Hickey AC; Choudhry V; Dimitrov DS; Eaton BT; Wang LF
    J Virol Methods; 2007 Jun; 142(1-2):29-40. PubMed ID: 17292974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developments towards effective treatments for Nipah and Hendra virus infection.
    Bossart KN; Broder CC
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):43-55. PubMed ID: 16441208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus.
    Bradel-Tretheway BG; Liu Q; Stone JA; McInally S; Aguilar HC
    J Virol; 2015 Jul; 89(14):7235-47. PubMed ID: 25948743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization strategies against henipaviruses.
    Broder CC; Geisbert TW; Xu K; Nikolov DB; Wang LF; Middleton D; Pallister J; Bossart KN
    Curr Top Microbiol Immunol; 2012; 359():197-223. PubMed ID: 22481140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hendra and Nipah viruses: pathogenesis and therapeutics.
    Eaton BT; Broder CC; Wang LF
    Curr Mol Med; 2005 Dec; 5(8):805-16. PubMed ID: 16375714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.
    Bossart KN; Rockx B; Feldmann F; Brining D; Scott D; LaCasse R; Geisbert JB; Feng YR; Chan YP; Hickey AC; Broder CC; Feldmann H; Geisbert TW
    Sci Transl Med; 2012 Aug; 4(146):146ra107. PubMed ID: 22875827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Nipah and Hendra Viruses Using Recombinant Human Ephrin B2 Capture Virus in Immunoassays.
    Yang M; Zhu W; Truong T; Pickering B; Babiuk S; Kobasa D; Banadyga L
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection.
    Mire CE; Chan YP; Borisevich V; Cross RW; Yan L; Agans KN; Dang HV; Veesler D; Fenton KA; Geisbert TW; Broder CC
    J Infect Dis; 2020 May; 221(Suppl 4):S471-S479. PubMed ID: 31686101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS.
    Zhang MY; Choudhry V; Xiao X; Dimitrov DS
    Curr Opin Mol Ther; 2005 Apr; 7(2):151-6. PubMed ID: 15844623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Passive immunization and active vaccination against Hendra and Nipah viruses.
    Broder CC
    Dev Biol (Basel); 2013; 135():125-38. PubMed ID: 23689890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptome Profiling of the Virus-Induced Innate Immune Response in Pteropus vampyrus and Its Attenuation by Nipah Virus Interferon Antagonist Functions.
    Glennon NB; Jabado O; Lo MK; Shaw ML
    J Virol; 2015 Aug; 89(15):7550-66. PubMed ID: 25972557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to combat viral infections: development strategies and progress.
    Pantaleo G; Correia B; Fenwick C; Joo VS; Perez L
    Nat Rev Drug Discov; 2022 Sep; 21(9):676-696. PubMed ID: 35725925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.
    Fischer K; Diederich S; Smith G; Reiche S; Pinho Dos Reis V; Stroh E; Groschup MH; Weingartl HM; Balkema-Buschmann A
    PLoS One; 2018; 13(4):e0194385. PubMed ID: 29708971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viruses in bats and potential spillover to animals and humans.
    Wang LF; Anderson DE
    Curr Opin Virol; 2019 Feb; 34():79-89. PubMed ID: 30665189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system.
    Defang GN; Khetawat D; Broder CC; Quinnan GV
    Vaccine; 2010 Dec; 29(2):212-20. PubMed ID: 21050901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
    Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
    J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization and diagnostic evaluation of monoclonal antibody-based blocking ELISA formats for detection of neutralizing antibodies to Hendra virus in mammalian sera.
    Di Rubbo A; McNabb L; Klein R; White JR; Colling A; Dimitrov DS; Broder CC; Middleton D; Lunt RA
    J Virol Methods; 2019 Dec; 274():113731. PubMed ID: 31513861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hendra virus and Nipah virus animal vaccines.
    Broder CC; Weir DL; Reid PA
    Vaccine; 2016 Jun; 34(30):3525-34. PubMed ID: 27154393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhabdovirus-based vaccine platforms against henipaviruses.
    Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
    J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.
    van den Brink EN; Ter Meulen J; Cox F; Jongeneelen MA; Thijsse A; Throsby M; Marissen WE; Rood PM; Bakker AB; Gelderblom HR; Martina BE; Osterhaus AD; Preiser W; Doerr HW; de Kruif J; Goudsmit J
    J Virol; 2005 Feb; 79(3):1635-44. PubMed ID: 15650189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.